Zolpidem Displays Heterogeneity in Its Binding to the Nonhuman Primate Benzodiazepine Receptor In Vivo
The DOI matches its Crossref record.
Abstract
The distinctive pharmacological activity of zolpidem in rats compared with classical benzodiazepines has been related to its differential affinity for benzodiazepine receptor (BZR) subtypes. By contrast, in nonhuman primates the pharmacological activity of zolpidem was found to be quite similar to that of classical BZR agonists. In an attempt to explain this discrepancy, we examined the ability of zolpidem to differentiate BZR subtypes in vivo in primate brain using positron emission tomography. The BZRs were specifically labeled with [11 C]flumazenil. Radiotracer displacement by zolpidem was monophasic in cerebellum and neocortex, with in vivo Hill coefficients close to 1. Conversely, displacement of [11 C]flumazenil was biphasic in hippocampus, amygdala, septum, insula, striatum, and pons, with Hill coefficients significantly smaller than 1, suggesting two different binding sites for zolpidem. In these cerebral regions, the half‐maximal inhibitory doses for the high‐affinity binding site were similar to those found in cerebellum and neocortex and ∼100‐fold higher for the low‐affinity binding site. The low‐affinity binding site accounted for <32% of the specific [11 C]‐flumazenil binding. Such zolpidem binding characteristics contrast with those reported for rodents, where three different binding sites were found. Species differences in binding characteristics may explain why zolpidem has a distinctive pharmacological activity in rodents, whereas its pharmacological activity in primates is quite similar to that of classical BZR agonists, except for the absence of severe effects on memory functions, which may be due to the lack of substantial zolpidem affinity for a distinct BZR subtype in cerebral structures belonging to the limbic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gottesmann, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00034-9 · Cited by 439
Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory
Mattila, M. J., Vanakoski, J., Kalska, H., & Seppälä, T. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00506-6 · Cited by 70
The Pharmacology and Mechanism of Action of Zolpidem
Sanger, D. J., & Depoortere, H. (1998) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1998.tb00074.x · Cited by 58
“The binding of zolpidem to BZ(ω) receptors in different regions of the CNS has also been investigated in vivo in rodents sacrificed after systemic administration of drug and labeled ligand (10,11) and in baboons and humans using positron emission tomography (1,76).”
Pharmacological principles for safe benzodiazepine and Z-drug dose reduction
Horowitz, M., Lamberson, N., Brandt, J., Framer, A., Shapiro, B., Sørensen, A., Cadogan, C., Ritvo, A., & Taylor, D. (2026) · Psychological Medicine · doi:10.1017/s0033291726104887
“Many immediate-release, non – enteric-coated tablets can be crushed and dispersed in water without major (Nair & Jacob, 2016; Schmid et al., 1995) Zopiclone 7.5 mg 5 – 6 3.75 mg, 7.5 mg N/A 1.4 (Benavides et al., 1992; Nair & Jacob, 2016) a -”
Influential
Metadata
- Authors
- Schmid, L., Bottlaender, M., Fuseau, C., Fournier, D., Brouillet, E., & Mazière, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1995-10
- Volume
- 65
- Issue
- 4
- Pages
- 1880-1886
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2014419597
- Cited by
- 33
- References
- 0
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zolpidem Displays Heterogeneity in Its Binding to the Nonhuman Primate Benzodiazepine Receptor In Vivo. https://app.cochat.ai/papers/10.1046/j.1471-4159.1995.65041880.x
- The paper
- Schmid, L., Bottlaender, M., Fuseau, C., Fournier, D., Brouillet, E., & Mazière, M. (1995). Zolpidem Displays Heterogeneity in Its Binding to the Nonhuman Primate Benzodiazepine Receptor In Vivo. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.1995.65041880.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.